Skip to main content
. 2021 Apr 15;21:174. doi: 10.1186/s12876-021-01738-0

Table 2.

Co-medications used with linaclotide

Prior medications continued with linaclotide (%) Co-medications initiated while on linaclotide (%)
Polyethylene glycol 17 (55%) 4 (13%)
Senna 5 (16%) 5 (16%)
Oral docusate 8 (26%) 2 (6%)
Docusate suppository 2 (6%) 2 (6%)
Lubiprostone 3 (10%) 0
Pyridostigmine 3 (10%) 8 (26%)
Prucalopride 1 (3%) 0
Domperidone 3 (10%) 0
Erythromycin 0 2 (6%)
Metoclopramide 5 (16%) 1 (3%)
Probiotics 8 (26%) 2 (6%)
Methylnaltrexone 0 3 (10%)